insights_auto
Outlook: 23.1% bullish·0.0% bearish
Go to analysischevron_right
DDNB34:BVMF
Dupont De Nemours Inc BDR
R$655.27
0.00%
(0.00) 1D
Oct 8, 1:45:18 PM GMT-3 · BRL
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DDNB34...
Mkt. cap
20.36B
Avg. vol.
25.00
Volume
0.00
52-wk high
R$776.71
52-wk low
R$597.12
Shares outstanding
135.04M
No. of employees
15K
Mkt. cap
20.36B
Avg. vol.
25.00
Volume
0.00
52-wk high
R$776.71
52-wk low
R$597.12
Shares outstanding
135.04M
No. of employees
15K
News stories
From web sources and news partners
MarketWatch
·
6 hours ago
DuPont de Nemours Inc. stock underperforms Wednesday when compared to competitors
Investing.com
·
13 hours ago
UBS raises DuPont stock price target to $182 on margin strength
Trefis
·
15 hours ago
What Just Happened To DuPont Stock?
The Globe and Mail
·
1 day ago
Why DuPont Stock Trounced the Market on Tuesday
Profile
DuPont de Nemours, Inc., commonly shortened to DuPont, is a company headquartered and organized in Delaware that produces products for the healthcare, water, construction and industrial markets. It was formed in 1802 by French-American chemist and industrialist Éleuthère Irénée du Pont de Nemours.
The company operates two divisions: Healthcare & Water Technologies, which produces medical packaging such as Tyvek packaging and Tychem protective suits as well as Amberlite ion exchange resins, Filmtec reverse osmosis and nanofiltration elements and Inge and Itegratec ultrafiltration modules; and Diversified Industrials, which produces products for repair‑and‑remodel construction such as Tyvek house wrap, Styrofoam insulation, Corian, Vespel shapes and parts, Molykote lubricants, Betaforce, and Betaseal.
The company played a major role in the development of the U.S. state of Delaware and first arose as a major supplier of gunpowder. Wikipedia
About Dupont De Nemours Inc BDR
CEOLori Koch
Employees15K
FoundedAug 31, 2017
Headquarters-
SectorConglomerate
Industry-
Websitedupont.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 3.07B | -1.87B | 1.68B | 1.82B |
Cost of goods sold | 1.88B | -816.00M | 1.08B | 1.18B |
Cost of revenue | 1.88B | -816.00M | 1.08B | 1.18B |
Research and development expenses | 140.00M | -211.00M | 47.00M | 42.00M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 388.00M | -111.00M | 255.00M | 270.00M |
Operating expense | 649.00M | -406.00M | 370.00M | 380.00M |
Total operating expenses | 2.53B | -1.22B | 1.45B | 1.56B |
Operating income | 546.00M | -649.00M | 232.00M | 259.00M |
Other non operating income | 5.00M | -46.00M | 10.00M | 4.00M |
EBT including unusual items | 327.00M | -738.00M | 181.00M | 266.00M |
EBT excluding unusual items | 482.00M | -719.00M | 221.00M | 262.00M |
Income tax expense | 19.00M | -89.00M | 31.00M | 75.00M |
Effective tax rate | 5.81% | 12.06% | 17.13% | 28.20% |
Other operating expenses | - | - | - | - |
Net income | -123.00M | -126.00M | 161.00M | 143.00M |
Net profit margin | -4.00% | 6.73% | 9.58% | 7.86% |
Earnings per share | 3.27 | 1.38 | 1.65 | 1.88 |
Interest and investment income | 27.00M | 30.00M | 10.00M | 27.00M |
Interest expense | -99.00M | -16.00M | -40.00M | -41.00M |
Net interest expenses | -72.00M | 14.00M | -30.00M | -14.00M |
Depreciation and amortization charges | - | -84.00M | - | - |
EBITDA | 729.00M | -487.25M | 387.00M | 413.00M |
Gain or loss from assets sale | - | -3.00M | - | - |
Upcoming events